• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者对大剂量沙丁胺醇和茶碱的反应。

Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.

作者信息

Filuk R B, Easton P A, Anthonisen N R

出版信息

Am Rev Respir Dis. 1985 Oct;132(4):871-4. doi: 10.1164/arrd.1985.132.4.871.

DOI:10.1164/arrd.1985.132.4.871
PMID:4051322
Abstract

To assess additive effects of therapy with salbutamol and theophylline, we examined 16 patients (5 women, 11 men) with a mean age of 67.6 +/- 6.9 (SE) yr, long-standing chronic obstructive pulmonary disease, an FEV1 of 0.73 +/- 0.05 (SE) L, and a smoking history of 38.4 +/- 4.1 (SE) pack-years. On 2 consecutive days they were given large doses of either salbutamol followed by theophylline or vice versa. In the group as a whole, responses to salbutamol alone averaged 24% of the baseline FEV1 and responses to theophylline alone were 17% of baseline. Similar increases were observed when either drug was given after the other; responses to the 2 agents were additive. Responses to salbutamol were larger (p less than 0.05) than those to theophylline. Responses to salbutamol and theophylline were correlated. In 8 patients whose FEV1 increased after salbutamol by more than both 20% and 0.2 L, adding theophylline produced responses that were also large (32% baseline and 0.22 L). In the remaining 8 nonresponsive patients, salbutamol and theophylline were also additive, but the small (mean 10% or 0.06 L) increases in FEV1 with theophylline raised the question of the risk benefit ratio of high-dose theophylline therapy in such patients.

摘要

为评估沙丁胺醇与茶碱联合治疗的附加效应,我们对16例患者(5例女性,11例男性)进行了研究,这些患者的平均年龄为67.6±6.9(标准误)岁,患有长期慢性阻塞性肺疾病,第一秒用力呼气容积(FEV1)为0.73±0.05(标准误)L,吸烟史为38.4±4.1(标准误)包年。在连续2天里,他们被给予大剂量的沙丁胺醇后再给予茶碱,或者反之。在整个组中,单独使用沙丁胺醇时的反应平均为基线FEV1的24%,单独使用茶碱时的反应为基线的17%。当两种药物先后给予时观察到类似的增加;对两种药物的反应是相加的。对沙丁胺醇的反应大于对茶碱的反应(P<0.05)。对沙丁胺醇和茶碱的反应具有相关性。在8例使用沙丁胺醇后FEV1增加超过20%且增加量超过0.2 L的患者中,加用茶碱后的反应也很大(为基线的32%和增加0.22 L)。在其余8例无反应的患者中,沙丁胺醇和茶碱的作用也是相加的,但茶碱使FEV1出现的较小增加(平均10%或0.06 L)引发了对于此类患者高剂量茶碱治疗风险效益比的疑问。

相似文献

1
Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者对大剂量沙丁胺醇和茶碱的反应。
Am Rev Respir Dis. 1985 Oct;132(4):871-4. doi: 10.1164/arrd.1985.132.4.871.
2
Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.茶碱和沙丁胺醇可改善不可逆性慢性阻塞性肺疾病患者的肺功能。
Chest. 1992 Jan;101(1):160-5. doi: 10.1378/chest.101.1.160.
3
[Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
Rev Hosp Clin Fac Med Sao Paulo. 1991 Jul-Aug;46(4):166-9.
4
The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.口服氨茶碱、吸入沙丁胺醇以及两者联合使用作为慢性治疗手段,用于管理伴有可逆性气流受限的慢性支气管炎的疗效。
Am Rev Respir Dis. 1985 May;131(5):747-51. doi: 10.1164/arrd.1985.131.5.747.
5
The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.茶碱对稳定期慢性阻塞性肺疾病患者吸入高剂量沙丁胺醇与异丙托溴铵联合用药的附加效应。
Chest. 1995 Mar;107(3):718-23. doi: 10.1378/chest.107.3.718.
6
[Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy].
Fortschr Med. 1989 Apr 10;107(11):255-8.
7
Interactive effects of systemically administered salbutamol and aminophylline in patients with chronic obstructive pulmonary disease.全身性应用沙丁胺醇和氨茶碱对慢性阻塞性肺疾病患者的交互作用。
Am Rev Respir Dis. 1988 Dec;138(6):1499-503. doi: 10.1164/ajrccm/138.6.1499.
8
Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.慢性气流受限中的支气管扩张剂。对气道功能、运动能力和生活质量的影响。
Am Rev Respir Dis. 1987 May;135(5):1069-74. doi: 10.1164/arrd.1987.135.5.1069.
9
Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.植物性制剂用于慢性阻塞性肺疾病的管理:一项随机双盲研究。
Respir Med. 2006 Jan;100(1):39-45. doi: 10.1016/j.rmed.2005.04.011.
10
Mechanism of bronchodilator effect in chronic airflow limitation.慢性气流受限中支气管扩张剂作用的机制。
CMAJ. 1991 Jan 1;144(1):35-9.

引用本文的文献

1
Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的药物治疗
Drugs Aging. 1998 Feb;12(2):129-37. doi: 10.2165/00002512-199812020-00005.
2
Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.异丙托溴铵气雾剂对稳定期慢性阻塞性肺疾病患者最大运动能力的剂量反应研究。
Thorax. 1996 Jan;51(1):48-53. doi: 10.1136/thx.51.1.48.
3
Differences in utilisation of asthma drugs between two neighbouring Swedish provinces: relation to prevalence of obstructive airway disease.
瑞典两个相邻省份哮喘药物使用情况的差异:与阻塞性气道疾病患病率的关系。
Thorax. 1994 Jan;49(1):41-9. doi: 10.1136/thx.49.1.41.
4
What role for theophylline?茶碱起什么作用?
Thorax. 1994 Feb;49(2):97-100. doi: 10.1136/thx.49.2.97.
5
Chronic obstructive pulmonary disease.慢性阻塞性肺疾病
CMAJ. 1988 Mar 15;138(6):503-10.
6
Bronchodilator effect and serum theophylline level after combined treatment with fenoterol and theophylline in reversible chronic airflow obstruction.非诺特罗与茶碱联合治疗可逆性慢性气流阻塞后的支气管扩张作用及血清茶碱水平
Eur J Clin Pharmacol. 1988;35(6):669-71. doi: 10.1007/BF00637605.
7
Salbutamol in the 1980s. A reappraisal of its clinical efficacy.20世纪80年代的沙丁胺醇。对其临床疗效的重新评估。
Drugs. 1989 Jul;38(1):77-122. doi: 10.2165/00003495-198938010-00004.
8
Management of asthma and chronic airflow limitation: are methylxanthines obsolete?哮喘与慢性气流受限的管理:甲基黄嘌呤类药物过时了吗?
Lung. 1990;168 Suppl:634-41. doi: 10.1007/BF02718188.
9
Risk/benefit ratio of long-term treatment with beta 2-adrenoceptor agonists.β2肾上腺素能受体激动剂长期治疗的风险/效益比。
Lung. 1990;168 Suppl:168-76. doi: 10.1007/BF02718129.
10
Guidelines for the assessment and management of chronic obstructive pulmonary disease. Canadian Thoracic Society Workshop Group.慢性阻塞性肺疾病评估与管理指南。加拿大胸科学会 workshop 小组
CMAJ. 1992 Aug 15;147(4):420-8.